Structure

Physi-Chem Properties

Molecular Weight:  462.24
Volume:  496.137
LogP:  7.042
LogD:  4.586
LogS:  -2.869
# Rotatable Bonds:  7
TPSA:  83.06
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.336
Synthetic Accessibility Score:  3.784
Fsp3:  0.379
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.836
MDCK Permeability:  1.504674492025515e-05
Pgp-inhibitor:  0.89
Pgp-substrate:  0.175
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.949
30% Bioavailability (F30%):  0.417

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.013
Plasma Protein Binding (PPB):  98.49634552001953%
Volume Distribution (VD):  0.886
Pgp-substrate:  1.8713418245315552%

ADMET: Metabolism

CYP1A2-inhibitor:  0.718
CYP1A2-substrate:  0.2
CYP2C19-inhibitor:  0.881
CYP2C19-substrate:  0.069
CYP2C9-inhibitor:  0.528
CYP2C9-substrate:  0.97
CYP2D6-inhibitor:  0.844
CYP2D6-substrate:  0.856
CYP3A4-inhibitor:  0.379
CYP3A4-substrate:  0.119

ADMET: Excretion

Clearance (CL):  7.601
Half-life (T1/2):  0.165

ADMET: Toxicity

hERG Blockers:  0.072
Human Hepatotoxicity (H-HT):  0.963
Drug-inuced Liver Injury (DILI):  0.523
AMES Toxicity:  0.015
Rat Oral Acute Toxicity:  0.097
Maximum Recommended Daily Dose:  0.955
Skin Sensitization:  0.654
Carcinogencity:  0.045
Eye Corrosion:  0.003
Eye Irritation:  0.087
Respiratory Toxicity:  0.776

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC53640

Natural Product ID:  NPC53640
Common Name*:   Mulberrofuran X
IUPAC Name:   7-[(2E)-3,7-dimethylocta-2,6-dienyl]-2-[(2R)-6-hydroxy-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-4-yl]-1-benzofuran-6-ol
Synonyms:   Mulberrofuran X
Standard InCHIKey:  HDAQXXCKXVBBEI-XHLFLETQSA-N
Standard InCHI:  InChI=1S/C29H34O5/c1-17(2)7-6-8-18(3)9-11-21-24(31)12-10-19-13-25(34-28(19)21)22-14-20(30)15-26-23(22)16-27(33-26)29(4,5)32/h7,9-10,12-15,27,30-32H,6,8,11,16H2,1-5H3/b18-9+/t27-/m1/s1
SMILES:  CC(=CCC/C(=C/Cc1c(ccc2cc(c3cc(cc4c3C[C@H](C(C)(C)O)O4)O)oc12)O)/C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL459623
PubChem CID:   11798274
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. PMID[11429996]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT924 Cell Line HSC-2 Homo sapiens CC50 = 290000.0 nM PMID[476186]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. CC50 = 260000.0 nM PMID[476186]
NPT27 Others Unspecified CC50 = 350000.0 nM PMID[476186]
NPT27 Others Unspecified Ratio = 1.2 n.a. PMID[476186]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC53640 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9679 High Similarity NPC220582
0.9679 High Similarity NPC304839
0.9423 High Similarity NPC297531
0.9423 High Similarity NPC148938
0.9423 High Similarity NPC213936
0.9371 High Similarity NPC74854
0.9371 High Similarity NPC45124
0.9371 High Similarity NPC30655
0.9359 High Similarity NPC235333
0.9321 High Similarity NPC476459
0.9304 High Similarity NPC246647
0.9304 High Similarity NPC96342
0.9304 High Similarity NPC268360
0.9304 High Similarity NPC164110
0.9304 High Similarity NPC212967
0.9295 High Similarity NPC207624
0.9295 High Similarity NPC142308
0.9245 High Similarity NPC40583
0.9241 High Similarity NPC180924
0.9231 High Similarity NPC23668
0.9231 High Similarity NPC193976
0.9231 High Similarity NPC58668
0.9231 High Similarity NPC106372
0.9231 High Similarity NPC170169
0.9231 High Similarity NPC115324
0.9207 High Similarity NPC120220
0.9187 High Similarity NPC470810
0.9177 High Similarity NPC99199
0.9177 High Similarity NPC198490
0.9167 High Similarity NPC472421
0.9167 High Similarity NPC230713
0.9167 High Similarity NPC78335
0.9152 High Similarity NPC472584
0.9136 High Similarity NPC472581
0.9114 High Similarity NPC213608
0.9114 High Similarity NPC183874
0.9114 High Similarity NPC1477
0.9114 High Similarity NPC472462
0.9108 High Similarity NPC474744
0.9108 High Similarity NPC474772
0.9108 High Similarity NPC472423
0.9103 High Similarity NPC178202
0.9103 High Similarity NPC226644
0.9103 High Similarity NPC37226
0.9085 High Similarity NPC247973
0.908 High Similarity NPC39306
0.908 High Similarity NPC300053
0.9074 High Similarity NPC219861
0.9074 High Similarity NPC472402
0.9062 High Similarity NPC296957
0.9062 High Similarity NPC65504
0.9062 High Similarity NPC260902
0.9051 High Similarity NPC5871
0.9051 High Similarity NPC477957
0.9051 High Similarity NPC473996
0.9051 High Similarity NPC476238
0.9051 High Similarity NPC327269
0.9051 High Similarity NPC31627
0.9038 High Similarity NPC135325
0.9024 High Similarity NPC119589
0.9024 High Similarity NPC277480
0.9018 High Similarity NPC472582
0.9018 High Similarity NPC133065
0.9012 High Similarity NPC96031
0.9006 High Similarity NPC476349
0.9006 High Similarity NPC476350
0.9 High Similarity NPC247677
0.9 High Similarity NPC160015
0.8988 High Similarity NPC312630
0.8988 High Similarity NPC324220
0.8987 High Similarity NPC472636
0.8987 High Similarity NPC472580
0.8987 High Similarity NPC471675
0.8982 High Similarity NPC310794
0.8981 High Similarity NPC296030
0.8981 High Similarity NPC39929
0.8976 High Similarity NPC131866
0.8974 High Similarity NPC14875
0.8974 High Similarity NPC130581
0.8974 High Similarity NPC17816
0.8974 High Similarity NPC12148
0.8963 High Similarity NPC37183
0.8957 High Similarity NPC84515
0.8957 High Similarity NPC312056
0.8951 High Similarity NPC328102
0.8931 High Similarity NPC285623
0.8929 High Similarity NPC227906
0.8924 High Similarity NPC13282
0.8924 High Similarity NPC167576
0.891 High Similarity NPC210826
0.891 High Similarity NPC51641
0.891 High Similarity NPC300267
0.8909 High Similarity NPC170245
0.8902 High Similarity NPC124038
0.8902 High Similarity NPC109180
0.8902 High Similarity NPC471286
0.8896 High Similarity NPC304387
0.8896 High Similarity NPC3629
0.8896 High Similarity NPC188486
0.8896 High Similarity NPC92589
0.8896 High Similarity NPC269117
0.8889 High Similarity NPC210459
0.8882 High Similarity NPC208152
0.8882 High Similarity NPC78492
0.8882 High Similarity NPC104682
0.8875 High Similarity NPC100134
0.8875 High Similarity NPC72370
0.8875 High Similarity NPC210942
0.8875 High Similarity NPC303950
0.8875 High Similarity NPC209760
0.8875 High Similarity NPC169990
0.8875 High Similarity NPC122365
0.8868 High Similarity NPC244577
0.8868 High Similarity NPC471677
0.8868 High Similarity NPC471676
0.8868 High Similarity NPC472420
0.8868 High Similarity NPC263384
0.8868 High Similarity NPC472422
0.8861 High Similarity NPC317492
0.8861 High Similarity NPC65775
0.8861 High Similarity NPC221868
0.8861 High Similarity NPC37208
0.8861 High Similarity NPC10027
0.8855 High Similarity NPC50394
0.8855 High Similarity NPC150131
0.8848 High Similarity NPC108433
0.8848 High Similarity NPC326520
0.8848 High Similarity NPC472277
0.8848 High Similarity NPC474591
0.8848 High Similarity NPC136641
0.8848 High Similarity NPC293319
0.8846 High Similarity NPC155144
0.8846 High Similarity NPC98926
0.8846 High Similarity NPC230943
0.8841 High Similarity NPC272722
0.8841 High Similarity NPC472964
0.8841 High Similarity NPC201800
0.8834 High Similarity NPC472624
0.8834 High Similarity NPC321399
0.8834 High Similarity NPC36217
0.8834 High Similarity NPC471976
0.8834 High Similarity NPC299436
0.8827 High Similarity NPC196448
0.882 High Similarity NPC477958
0.8812 High Similarity NPC210597
0.8812 High Similarity NPC263676
0.8812 High Similarity NPC67654
0.8812 High Similarity NPC253872
0.8805 High Similarity NPC476509
0.8802 High Similarity NPC211309
0.8802 High Similarity NPC53252
0.8802 High Similarity NPC288813
0.8797 High Similarity NPC272194
0.8797 High Similarity NPC168085
0.8795 High Similarity NPC235610
0.879 High Similarity NPC316769
0.8788 High Similarity NPC205265
0.8788 High Similarity NPC18100
0.8788 High Similarity NPC475985
0.8788 High Similarity NPC186686
0.8788 High Similarity NPC91288
0.8788 High Similarity NPC472281
0.8782 High Similarity NPC302181
0.8782 High Similarity NPC225884
0.878 High Similarity NPC474187
0.878 High Similarity NPC474186
0.878 High Similarity NPC14822
0.8779 High Similarity NPC475148
0.8779 High Similarity NPC475656
0.8773 High Similarity NPC16935
0.8773 High Similarity NPC196879
0.8765 High Similarity NPC478223
0.8765 High Similarity NPC24640
0.8765 High Similarity NPC45131
0.8758 High Similarity NPC7989
0.8758 High Similarity NPC293286
0.8758 High Similarity NPC472583
0.8758 High Similarity NPC223701
0.8758 High Similarity NPC469405
0.8757 High Similarity NPC98776
0.8757 High Similarity NPC277510
0.875 High Similarity NPC116604
0.875 High Similarity NPC471229
0.875 High Similarity NPC232645
0.875 High Similarity NPC478148
0.875 High Similarity NPC156244
0.875 High Similarity NPC149526
0.875 High Similarity NPC72958
0.875 High Similarity NPC313717
0.875 High Similarity NPC474417
0.875 High Similarity NPC315306
0.8743 High Similarity NPC320789
0.8743 High Similarity NPC218226
0.8742 High Similarity NPC472628
0.8736 High Similarity NPC73929
0.8736 High Similarity NPC139683
0.8736 High Similarity NPC47905
0.8735 High Similarity NPC38914
0.8735 High Similarity NPC204088
0.8735 High Similarity NPC291110

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC53640 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8642 High Similarity NPD2393 Clinical (unspecified phase)
0.8538 High Similarity NPD6559 Discontinued
0.8537 High Similarity NPD3882 Suspended
0.8528 High Similarity NPD7819 Suspended
0.8485 Intermediate Similarity NPD3749 Approved
0.8485 Intermediate Similarity NPD7075 Discontinued
0.8466 Intermediate Similarity NPD1934 Approved
0.8457 Intermediate Similarity NPD4380 Phase 2
0.8443 Intermediate Similarity NPD6959 Discontinued
0.8415 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8383 Intermediate Similarity NPD5494 Approved
0.8375 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8364 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8353 Intermediate Similarity NPD7473 Discontinued
0.8304 Intermediate Similarity NPD3818 Discontinued
0.8303 Intermediate Similarity NPD2801 Approved
0.8284 Intermediate Similarity NPD6232 Discontinued
0.8261 Intermediate Similarity NPD2534 Approved
0.8261 Intermediate Similarity NPD2533 Approved
0.8261 Intermediate Similarity NPD2532 Approved
0.8261 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8228 Intermediate Similarity NPD1549 Phase 2
0.8187 Intermediate Similarity NPD6166 Phase 2
0.8187 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8165 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8165 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8165 Intermediate Similarity NPD2344 Approved
0.816 Intermediate Similarity NPD920 Approved
0.8155 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.815 Intermediate Similarity NPD5844 Phase 1
0.8133 Intermediate Similarity NPD6801 Discontinued
0.8129 Intermediate Similarity NPD3926 Phase 2
0.8118 Intermediate Similarity NPD1247 Approved
0.8101 Intermediate Similarity NPD2796 Approved
0.8095 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD7768 Phase 2
0.8086 Intermediate Similarity NPD1511 Approved
0.8086 Intermediate Similarity NPD6799 Approved
0.8072 Intermediate Similarity NPD7411 Suspended
0.8063 Intermediate Similarity NPD2800 Approved
0.8046 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8038 Intermediate Similarity NPD1510 Phase 2
0.8037 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8013 Intermediate Similarity NPD1240 Approved
0.8012 Intermediate Similarity NPD6599 Discontinued
0.8 Intermediate Similarity NPD7074 Phase 3
0.8 Intermediate Similarity NPD919 Approved
0.7988 Intermediate Similarity NPD1512 Approved
0.7977 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7963 Intermediate Similarity NPD2309 Approved
0.795 Intermediate Similarity NPD1243 Approved
0.7943 Intermediate Similarity NPD7054 Approved
0.7929 Intermediate Similarity NPD3817 Phase 2
0.7914 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7911 Intermediate Similarity NPD1607 Approved
0.7898 Intermediate Similarity NPD7472 Approved
0.7888 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD5402 Approved
0.7814 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7809 Intermediate Similarity NPD7251 Discontinued
0.7791 Intermediate Similarity NPD3750 Approved
0.779 Intermediate Similarity NPD8434 Phase 2
0.7765 Intermediate Similarity NPD1465 Phase 2
0.7765 Intermediate Similarity NPD7808 Phase 3
0.7764 Intermediate Similarity NPD2935 Discontinued
0.7759 Intermediate Similarity NPD7229 Phase 3
0.7753 Intermediate Similarity NPD6797 Phase 2
0.7738 Intermediate Similarity NPD3226 Approved
0.773 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD8313 Approved
0.7722 Intermediate Similarity NPD8312 Approved
0.7705 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD6234 Discontinued
0.7684 Intermediate Similarity NPD3751 Discontinued
0.7683 Intermediate Similarity NPD4628 Phase 3
0.7667 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD5761 Phase 2
0.7661 Intermediate Similarity NPD5760 Phase 2
0.7657 Intermediate Similarity NPD5710 Approved
0.7657 Intermediate Similarity NPD5711 Approved
0.7654 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD7390 Discontinued
0.764 Intermediate Similarity NPD7286 Phase 2
0.7619 Intermediate Similarity NPD5403 Approved
0.7607 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD2346 Discontinued
0.76 Intermediate Similarity NPD7199 Phase 2
0.7593 Intermediate Similarity NPD2799 Discontinued
0.7584 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7572 Intermediate Similarity NPD4966 Approved
0.7572 Intermediate Similarity NPD4967 Phase 2
0.7572 Intermediate Similarity NPD4965 Approved
0.7569 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD943 Approved
0.7557 Intermediate Similarity NPD3787 Discontinued
0.7556 Intermediate Similarity NPD5953 Discontinued
0.7547 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD6099 Approved
0.7546 Intermediate Similarity NPD6100 Approved
0.7546 Intermediate Similarity NPD1551 Phase 2
0.7541 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7526 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD4287 Approved
0.75 Intermediate Similarity NPD1471 Phase 3
0.75 Intermediate Similarity NPD5401 Approved
0.7487 Intermediate Similarity NPD8151 Discontinued
0.7486 Intermediate Similarity NPD7228 Approved
0.7485 Intermediate Similarity NPD3748 Approved
0.7469 Intermediate Similarity NPD6651 Approved
0.7435 Intermediate Similarity NPD6781 Approved
0.7435 Intermediate Similarity NPD6779 Approved
0.7435 Intermediate Similarity NPD6776 Approved
0.7435 Intermediate Similarity NPD6780 Approved
0.7435 Intermediate Similarity NPD6782 Approved
0.7435 Intermediate Similarity NPD6777 Approved
0.7435 Intermediate Similarity NPD6778 Approved
0.7427 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD2296 Approved
0.7412 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7411 Intermediate Similarity NPD7783 Phase 2
0.7411 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7409 Intermediate Similarity NPD7435 Discontinued
0.7405 Intermediate Similarity NPD8150 Discontinued
0.7399 Intermediate Similarity NPD37 Approved
0.7378 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD4625 Phase 3
0.7371 Intermediate Similarity NPD7871 Phase 2
0.7371 Intermediate Similarity NPD7870 Phase 2
0.7368 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD3764 Approved
0.7329 Intermediate Similarity NPD2313 Discontinued
0.7329 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD7697 Approved
0.732 Intermediate Similarity NPD7696 Phase 3
0.732 Intermediate Similarity NPD7698 Approved
0.7301 Intermediate Similarity NPD230 Phase 1
0.7299 Intermediate Similarity NPD6280 Approved
0.7299 Intermediate Similarity NPD6279 Approved
0.7294 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD6823 Phase 2
0.7263 Intermediate Similarity NPD6808 Phase 2
0.7259 Intermediate Similarity NPD7701 Phase 2
0.7246 Intermediate Similarity NPD2424 Discontinued
0.7239 Intermediate Similarity NPD4060 Phase 1
0.7239 Intermediate Similarity NPD1613 Approved
0.7239 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD5405 Approved
0.7229 Intermediate Similarity NPD5404 Approved
0.7229 Intermediate Similarity NPD5406 Approved
0.7229 Intermediate Similarity NPD5408 Approved
0.7228 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD1729 Discontinued
0.7208 Intermediate Similarity NPD7584 Approved
0.7205 Intermediate Similarity NPD6832 Phase 2
0.7205 Intermediate Similarity NPD4908 Phase 1
0.7195 Intermediate Similarity NPD447 Suspended
0.7195 Intermediate Similarity NPD6355 Discontinued
0.7193 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7874 Approved
0.7182 Intermediate Similarity NPD2403 Approved
0.7173 Intermediate Similarity NPD4363 Phase 3
0.7173 Intermediate Similarity NPD4360 Phase 2
0.7173 Intermediate Similarity NPD6534 Approved
0.7173 Intermediate Similarity NPD6535 Approved
0.7169 Intermediate Similarity NPD7033 Discontinued
0.716 Intermediate Similarity NPD3027 Phase 3
0.7159 Intermediate Similarity NPD8455 Phase 2
0.715 Intermediate Similarity NPD7700 Phase 2
0.715 Intermediate Similarity NPD7801 Approved
0.715 Intermediate Similarity NPD7699 Phase 2
0.7143 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7240 Approved
0.7135 Intermediate Similarity NPD4361 Phase 2
0.7135 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7129 Intermediate Similarity NPD7930 Approved
0.7126 Intermediate Similarity NPD7458 Discontinued
0.7125 Intermediate Similarity NPD1470 Approved
0.7125 Intermediate Similarity NPD1203 Approved
0.7104 Intermediate Similarity NPD7177 Discontinued
0.7099 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7003 Approved
0.7052 Intermediate Similarity NPD6273 Approved
0.7043 Intermediate Similarity NPD7685 Pre-registration
0.7037 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD8320 Phase 1
0.702 Intermediate Similarity NPD8319 Approved
0.7018 Intermediate Similarity NPD6190 Approved
0.7012 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD6798 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data